Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study
- PMID: 29970076
- PMCID: PMC6029339
- DOI: 10.1186/s12941-018-0283-8
Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study
Abstract
Background: Curable disease tuberculosis is becoming incurable or difficult to treat due to drug resistance. Multi drug resistance tuberculosis is a major health problem for less developed countries. Development of drug resistance is mainly as result of man related factors and poor lifestyle. Identifying predictors of drug resistance and working on them is the important way of reducing the expansion in high burden countries. Ethiopia is one of TB, TB/HIV, and multi-drug resistant tuberculosis (MDR-TB) high burden country globally. This study was aimed to assess predictor of MDR-TB in southwest part of Ethiopia.
Methods: Unmatched case control study was conducted in case to control ratio of 1:1.2 in southwest part of Ethiopia. The cases were recruited from confirmed MDR-TB patient enrolled on second line treatment in Shenen Gibe Hospital (MDR-TB treatment center of the prefecture) and the controls were recruited from previously TB patients who cured or patient with smear negative at the end of treatment month during the study period in the same area. The data was collected by structured questionnaire by interview and logistic regression analyses were used to identify predictors of MDR-TB. Odds ratios with 95% CI were computed to determine the predictors.
Result: From the total 132 participants about 45% of them were cases. None disclosed tuberculosis infected to relatives [AOR = 3.4, 95% CI (1.2-9.8)], insufficient instruction on how to take anti-TB drug [AOR = 4.7, 95% CI (1.4-14.6)], contact history with MDR-TB [AOR = 8.5, 95% CI (2.9-25.5)], interruption of first-line anti-TB treatment for at list 1 day [AOR = 7.9, 95% CI (2.5-24.9)], and having alcohol drinking habits [AOR = 5.1, 95% CI (1.4-18.7)] were identified predictors for MDR-TB infection in study area.
Conclusion: TB infection disclosure status, insufficient instruction on drug usage, contact history with MDR-TB, interruption of first-line anti-TB drugs, and alcohol drinking habits were identified predictor of MDR-TB case. Therefore, early detection and proper treatment of drug susceptible TB, strengthening directly observed treatment, short-course on daily bases, community involvement, and supporting the patient to intervene identified factors is paramount.
Keywords: Multi-drug resistance tuberculosis; Predictor; Southwest Ethiopia; Tuberculosis treatment.
Similar articles
-
Risk factors for multidrug resistant tuberculosis patients in Amhara National Regional State.Afr Health Sci. 2015 Jun;15(2):368-77. doi: 10.4314/ahs.v15i2.9. Afr Health Sci. 2015. PMID: 26124781 Free PMC article.
-
Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia.PLoS One. 2018 Jun 4;13(6):e0197737. doi: 10.1371/journal.pone.0197737. eCollection 2018. PLoS One. 2018. PMID: 29864118 Free PMC article.
-
Primary and secondary anti-tuberculosis drug resistance in Hitossa District of Arsi Zone, Oromia Regional State, Central Ethiopia.BMC Public Health. 2016 Jul 18;16:593. doi: 10.1186/s12889-016-3210-y. BMC Public Health. 2016. PMID: 27430266 Free PMC article.
-
Delamanid: From discovery to its use for pulmonary multidrug-resistant tuberculosis (MDR-TB).Tuberculosis (Edinb). 2018 Jul;111:20-30. doi: 10.1016/j.tube.2018.04.008. Epub 2018 May 3. Tuberculosis (Edinb). 2018. PMID: 30029909 Review.
-
Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.PLoS Med. 2018 Jul 11;15(7):e1002591. doi: 10.1371/journal.pmed.1002591. eCollection 2018 Jul. PLoS Med. 2018. PMID: 29995958 Free PMC article.
Cited by
-
A study on tuberculosis disease disclosure patterns and its associated factors: Findings from a prospective observational study in Chennai.PLoS One. 2023 Jan 26;18(1):e0280812. doi: 10.1371/journal.pone.0280812. eCollection 2023. PLoS One. 2023. PMID: 36701386 Free PMC article.
-
Tuberculosis control at a South African correctional centre: Diagnosis, treatment and strain characterisation.PLoS One. 2022 Nov 11;17(11):e0277459. doi: 10.1371/journal.pone.0277459. eCollection 2022. PLoS One. 2022. PMID: 36367892 Free PMC article.
-
Status of quality indicators in a mycobacteriology culture laboratory, Hawassa, Sidama, Ethiopia.SAGE Open Med. 2024 Sep 20;12:20503121241274716. doi: 10.1177/20503121241274716. eCollection 2024. SAGE Open Med. 2024. PMID: 39483617 Free PMC article.
-
Treatment Interruption Among Drug-Susceptible Pulmonary Tuberculosis Patients in Southern Ethiopia.Patient Prefer Adherence. 2021 May 26;15:1143-1151. doi: 10.2147/PPA.S307091. eCollection 2021. Patient Prefer Adherence. 2021. PMID: 34079235 Free PMC article.
-
Level of Family Support and Associated Factors Among Pulmonary Tuberculosis Patients in Eastern Uganda. A Baseline Cross-Sectional Study.J Multidiscip Healthc. 2025 Apr 12;18:2057-2073. doi: 10.2147/JMDH.S511615. eCollection 2025. J Multidiscip Healthc. 2025. PMID: 40242082 Free PMC article.
References
-
- World Health Organization. Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. Geneva: WHO; 2010. http://whqlibdoc.who.int/publications/2010/9789241599191_eng.pdf. Accessed 26 Sept 2018.
-
- World Health Organization. Anti-tuberculosis drug resistance in the world: fourth global report. Geneva: WHO, WHO/HTM/TB/2008.394. 2008.
-
- World Health Organization. Global tuberculosis report. WHO, 2016. http://www.who.int/tb/publications/global_report/gtbr2016_executive_summ.... Accessed 28 Sept 2018.
-
- Marahatta SB, Kaewkungwal J, Ramasoota P, Singhasivanon P. Risk factors of multidrug resistant tuberculosis in central Nepal. Kathmandu Univ Med J. 2010;8(32):392–397. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources